@article{d0a851ac667f45b79e7e083bfccec6f3,
title = "Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course",
abstract = "Levels of CXCL13, a potent B-cell chemoattractant, are elevated in the cerebrospinal fluid (CSF) during multiple sclerosis (MS) and are associated with markers of MS activity. Levels decrease upon effective treatments.",
keywords = "Adolescent, Adult, Aged, Biological Markers, Chemokine CXCL13, Demyelinating Diseases, Disability Evaluation, Disease Progression, Enzyme-Linked Immunosorbent Assay, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting, Oligoclonal Bands, Predictive Value of Tests, Prognosis, Reproducibility of Results, Sweden, Time Factors, Up-Regulation, Young Adult",
author = "Mohsen Khademi and Ingrid Kockum and Andersson, {Magnus L} and Ellen Iacobaeus and Lou Brundin and Finn Sellebjerg and Jan Hillert and Fredrik Piehl and Tomas Olsson",
year = "2011",
doi = "10.1177/1352458510389102",
language = "English",
volume = "17",
pages = "335--43",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "Sage Science Press (UK)",
number = "3",
}